Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7


Melatonin MT1 and MT2 Receptors Exhibit Distinct Effects in the Modulation of Body Temperature across the Light/Dark Cycle.

López-Canul M, Min SH, Posa L, De Gregorio D, Bedini A, Spadoni G, Gobbi G, Comai S.

Int J Mol Sci. 2019 May 17;20(10). pii: E2452. doi: 10.3390/ijms20102452.


d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders.

De Gregorio D, Enns JP, Nuñez NA, Posa L, Gobbi G.

Prog Brain Res. 2018;242:69-96. doi: 10.1016/bs.pbr.2018.07.008. Epub 2018 Aug 31. Review.


Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain.

De Gregorio D, McLaughlin RJ, Posa L, Ochoa-Sanchez R, Enns J, Lopez-Canul M, Aboud M, Maione S, Comai S, Gobbi G.

Pain. 2019 Jan;160(1):136-150. doi: 10.1097/j.pain.0000000000001386.


Targeting Melatonin MT2 Receptors: A Novel Pharmacological Avenue for Inflammatory and Neuropathic Pain.

Posa L, De Gregorio D, Gobbi G, Comai S.

Curr Med Chem. 2018;25(32):3866-3882. doi: 10.2174/0929867324666170209104926. Review.


d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology.

De Gregorio D, Comai S, Posa L, Gobbi G.

Int J Mol Sci. 2016 Nov 23;17(11). pii: E1953. Review.


The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors.

De Gregorio D, Posa L, Ochoa-Sanchez R, McLaughlin R, Maione S, Comai S, Gobbi G.

Pharmacol Res. 2016 Nov;113(Pt A):81-91. doi: 10.1016/j.phrs.2016.08.022. Epub 2016 Aug 17.


Methadone Reverses Analgesic Tolerance Induced by Morphine Pretreatment.

Posa L, Accarie A, Noble F, Marie N.

Int J Neuropsychopharmacol. 2016 Jun 29;19(7). pii: pyv108. doi: 10.1093/ijnp/pyv108. Print 2016 Jul.

Supplemental Content

Loading ...
Support Center